PUBLIC COMPANY
saveChildren's Hospital of Philadelphia
updated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- EP1Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
- phase224VA021; VATCH Trametinib for Ras/MAPK Pathway VAs
- —International Study of Cerebral Oxygenation and Electrical Activity During Major Neonatal Surgery
- phase224VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs
- EP1Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH
- phase2Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
- phase2Lurbinectedin in FET-Fused Tumors
- —Vaccine Immune Recovery After Leukemia
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that